May 6, 2020 / 3:06 PM / a month ago

BRIEF-Moody's Says Global Pharmaceuticals Pipeline Quality Ticks Up, While Patent Exposures Modestly Ebb

May 6 (Reuters) -

* MOODY’S SAYS GLOBAL PHARMACEUTICALS PIPELINE QUALITY TICKS UP, WHILE PATENT EXPOSURES MODESTLY EBB

* MOODY’S SAYS POTENTIAL DELAYS IN CLINICAL TRIAL ENROLLMENT DUE TO CORONAVIRUS GENERALLY DO NOT IMPACT MOODY’S PEAK SALES ESTIMATES FOR GLOBAL PHARMA

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below